B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GRM4

MOLECULAR TARGET

glutamate metabotropic receptor 4

UniProt: Q14833NCBI Gene: 29143 compounds

GRM4 (glutamate metabotropic receptor 4) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GRM4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Glutamic Acid3.0420
2Glutamic Acid3.0420
3bdb whuutdbjxjrkmk2.208

About GRM4 as a Drug Target

GRM4 (glutamate metabotropic receptor 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented GRM4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GRM4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.